Eriochem

Eriochem is a prominent Argentine pharmaceutical company specializing in the development and manufacture of high-potency oncology products and complex generic medicines. Founded in 1994 and headquartered in Paraná, the company focuses on "supergenerics" or value-added medicines, utilizing advanced drug delivery technologies to enhance the efficacy and safety of established therapeutic molecules. Eriochem operates state-of-the-art GMP-certified facilities for both active pharmaceutical ingredients (APIs) and finished dosage forms, exporting its portfolio to over 50 countries including the United States and European markets. They were notably the first Argentine firm to receive US FDA approval for an injectable oncology product. Their business model integrates internal R&D with specialized manufacturing capabilities to provide high-quality, affordable treatments for various solid tumors and hematological malignancies.